ProfileGDS4459 / ENSG00000215421
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 74% 83% 78% 61% 70% 73% 74% 81% 78% 76% 78% 75% 77% 74% 78% 66% 75% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.4674
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.1983
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.0678
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.8761
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.3370
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.573
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.6874
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.381
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.0578
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.7876
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.8978
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.7875
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.8677
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.3774
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.0878
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.9966
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.5175